7/8 September 2022
The US Food & Drug Administration's (FDA) budget for the fiscal year (FY) 2018 will be higher than the one for the FY 2017. This was approved by the U.S. Senate Subcommittee on Appropriations. The authority's budget is part of the Agriculture Appropriations Bill and includes 2.8 billion US$ discretionary funding for the FDA. This is 1 million over the FY2017 budget. Including user fee revenues, total FDA funding will be 5.2 billion US$ (which is 491 million US$ above FY2017). The bill also provides 60 million US$ as authorized in the 21st Century Cures Act.